The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Horak Ivan D since 2005.
The trader's CIK number is 1247903.
At the time of the last reporting, Horak Ivan D was the EVP, R&D, Chief Scie of Enzon Pharmaceuticals, Inc.. (stock ticker symbol ENZN).
Also see all insider trading activities at Enzon Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2011 | ENZN | 0 | $0 | 0 | $0 | 26,480 | $0 |
| 2010 | ENZN | 0 | $0 | 360,229 | $3,707,233 | 357,060 | $2,268,881 |
| 2009 | ENZN | 0 | $0 | 7,035 | $43,054 | 37,110 | $0 |
| 2008 | ENZN | 0 | $0 | 0 | $0 | 17,250 | $0 |
| 2006 | ENZN | 6,000 | $41,208 | 0 | $0 | 0 | $0 |
| 2005 | ENZN | 5,500 | $39,490 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2011-04-03 | ENZN | Option Ex | 26,480 | .00 | 0 |
| 2010-11-23 | ENZN | Option Ex | 3,000 | .00 | 0 |
| 2010-09-17 | ENZN | Sale | 200,000 | 10.63 | 2,126,600 |
| 2010-09-16 | ENZN | Sale | 1,700 | 10.67 | 18,132 |
| 2010-09-17 | ENZN | Option Ex | 242,000 | 7.27 | 1,759,340 |
| 2010-09-15 | ENZN | Sale | 57,200 | 10.81 | 618,217 |
| 2010-09-16 | ENZN | Option Ex | 2,000 | 7.14 | 14,280 |
| 2010-09-15 | ENZN | Option Ex | 70,200 | 7.05 | 495,261 |
| 2010-09-02 | ENZN | Option Ex | 20,000 | .00 | 0 |
| 2010-04-03 | ENZN | Option Ex | 19,860 | .00 | 0 |
| 2010-02-22 | ENZN | Sale | 101,329 | 9.32 | 944,284 |
| 2009-11-23 | ENZN | Option Ex | 2,250 | .00 | 0 |
| 2009-09-02 | ENZN | Option Ex | 15,000 | .00 | 0 |
| 2009-04-03 | ENZN | Option Ex | 19,860 | .00 | 0 |
| 2009-04-03 | ENZN | Sale | 7,035 | 6.12 | 43,054 |
| 2008-11-23 | ENZN | Option Ex | 2,250 | .00 | 0 |
| 2008-09-02 | ENZN | Option Ex | 15,000 | .00 | 0 |
| 2006-03-07 | ENZN | Buy | 3,000 | 6.87 | 20,604 |
| 2006-03-07 | ENZN | Buy | 3,000 | 6.87 | 20,604 |
| 2005-10-04 | ENZN | Buy | 5,500 | 7.18 | 39,490 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Horak Ivan D (EVP, R&D, Chief Scie of Enzon Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.